Sign in
4

Changes in Ownership

BioAge Labs, Inc. Filed Acc 0001415889-25-004854

Options or other derivatives

  • Principal Accounting Officer acquired 90,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Barton Shane Principal Accounting Officer 2025-02-18 Grant or award · Stock Option (Right to Buy) +90,000 90,000 D: show line 1 in the form
Loading xslF345X05/form4-02202025_090229.xml…